Prevalence and risk factors of reduced bone mineral density in HIV infected individuals / Sheron Goh Sir Loon
The commencement of antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-infected individuals has decreased HIV-related complications and improved survival. However, studies have shown that there is a higher prevalence of osteopenia/osteoporosis [reduced bone mineral density (BMD)]...
Saved in:
Main Author: | |
---|---|
Format: | Thesis |
Published: |
2018
|
Subjects: | |
Online Access: | http://studentsrepo.um.edu.my/11418/4/sheron.pdf http://studentsrepo.um.edu.my/11418/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The commencement of antiretroviral therapy (ART) in human immunodeficiency
virus (HIV)-infected individuals has decreased HIV-related complications and improved
survival. However, studies have shown that there is a higher prevalence of
osteopenia/osteoporosis [reduced bone mineral density (BMD)] in HIV-infected
individuals. The aim of our study was to determine the prevalence of
osteopenia/osteoporosis (reduced BMD), vitamin D level, the 10-year probability of
fracture risk, and its associated risk factors in HIV-infected and HIV-uninfected
individuals in Malaysia. HIV-infected individuals aged ≥25 years and virologically
suppressed on ART for at least 1 year, were recruited from September 2014-September
2016, at a tertiary hospital in Malaysia. HIV-uninfected individuals were recruited from
the community. BMD was assessed using dual X-ray absorptiometry (DXA), whilst the
10-year probability of fracture risk was calculated using the fracture risk assessment tool
(FRAX®). A total of 684 potential participants were approached; of which 640
participants agreed to participate (response rate=93.6%). Participants were then matched
for gender and age, finally giving 206 participants in each group. The majority of
participants were male (73.8%) and Chinese (64.1%) with the median age of 40 years old.
A significantly higher number of HIV-infected individuals (73.8%) had reduced BMD
when compared to HIV-uninfected individuals [(57.3%), p<0.001]. The prevalence of
osteoporosis was found to be significantly higher in HIV-infected individuals (14.1%)
when compared to HIV-uninfected individuals [(5.3%), p<0.001]. Similarly, vitamin D
deficiency (<50nmol/L) was significantly higher in HIV-infected (65.0%) compared to
uninfected individuals [(30.1%), p<0.001]. The 10-year probability of sustaining a hip
v
fracture in HIV-infected individuals (0.4%) was significantly higher than in HIVuninfected individuals (0.2%, p=0.003), but not in major osteoporotic fracture [HIVinfected (1.7%); HIV-uninfected (1.3%)] (p=0.066). Lower body mass index (BMI),
reduced physical activity and older age were risk factors that significantly associated with
reduced BMD in HIV-infected individuals. In conclusion, the prevalence of reduced
BMD, vitamin D deficiency and the 10-year probability of sustaining a hip fracture was
higher in HIV-infected compared to HIV-uninfected individuals. Lower BMI, reduced
physical activity and older age were found to be associated with reduced BMD in HIVinfected individuals. |
---|